Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 29, 2022
ValGenesis, Inc and LifeBee have partnered to deliver business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance,
read more
Wednesday, January 10, 2024
In a strategic partnership, ValGenesis, Inc., a leader in digital validation, and GMP Pros, Inc., an engineering and technical solutions provider specializing in FDA-regulated manufacturing, join forces to introduce an innovative suite of digital ...
read more
ValGenesis, Inc. has acquired Portugal-based 4Tune Engineering (4TE), a provider of manufacturing sciences and technologies (MS&T) that enable the world's most successful life sciences companies to model their risk management programs and improve ...
read more
Monday, February 10, 2020
Valeritas Holdings announced an agreement to sell substantially all of the business to Zealand Pharma, a Denmark-based biotechnology company.
read more
Valeant Pharmaceuticals International, Inc. has announced that the company will change its name to Bausch Health Companies Inc., effective in July 2018.
read more
Monday, February 29, 2016
Valeant Pharmaceuticals has announced that J. Michael Pearson has returned as Valeant's chief executive officer following his recovery from severe pneumonia and other complications, effective immediately.
read more
Thursday, December 17, 2015
Valeant Pharmaceuticals has announced new fulfillment agreements with Walgreens while indicating it intends to extend this distribution model to additional participating independent retail pharmacies. In conjunction with the fulfillment agreement, ...
read more
Wednesday, February 28, 2018
Valeant announced its subsidiary has entered into an exclusive license agreement with Kaken to develop and commercialize products containing KP-470.
read more
Wednesday, September 09, 2015
Valeant Pharmaceuticals and Progenics Pharmaceuticals have announced that the FDA has accepted for review Valeant's New Drug Application for RELISTOR® (methylnaltrexone bromide) Tablets for the treatment of opioid-induced constipation (OIC) in adult ...
read more
Wednesday, September 02, 2015
Valeant Pharmaceuticals has announced that its affiliate has entered into a collaboration agreement with AstraZeneca under which Valeant was granted an exclusive license to develop and commercialize brodalumab.
read more
VAI has partnered with Adents to provide its pharmaceutical customers with a complete solution to meet upcoming requirements under the Drug Supply Chain Security Act (DSCSA).
read more
Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.
read more
Wednesday, September 23, 2020
Vaccinex has entered into a collaboration agreement with Merck through a subsidiary, to evaluate the combination of Vaccinex’s investigational SEMA4D inhibitor, pepinemab and KEYTRUDA for advanced, recurrent or metastatic head and neck squamous cell ...
read more
Thursday, November 30, 2017
Catalent and Vaccinex will develop an ADC using Catalent’s SMARTag conjugation platform and GPEx cell line engineering technologies, and Vaccinex’s ActivMAb technology.
read more
Wednesday, February 24, 2021
Vaccinex announced Surface Oncology will be exercising its option to license the anti-CCR8 antibody discovered via Vaccinex’s ActivMAb antibody discovery and novel viral display platform.
read more